Evidence map›Paper›PMID 42278640›Full record

ArticleInternational journal of molecular sciences2026

Comparative Analysis Between the EuroClonality-NGS Approach and the LymphoTrack

Irene Della Starza, Vittorio Bellomarino, Mariangela Di Trani, Luca Vincenzo Cappelli, Orietta Spinelli, Roberta Cavagna, Manuela Tosi, Carolina Terragna, Silvia Armuzzi, Valentina Robustelli and 19 more

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Irene Della StarzaHematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy.ORCID 0000-0001-7909-8642
Vittorio BellomarinoHematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy.ORCID 0000-0002-4736-7171
Mariangela Di TraniHematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy.
Luca Vincenzo CappelliHematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy.ORCID 0000-0001-8090-3880
Orietta SpinelliHematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, 24127 Bergamo, Italy.ORCID 0000-0003-0374-1536
Roberta CavagnaHematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, 24127 Bergamo, Italy.ORCID 0000-0003-4353-2210
Manuela TosiHematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, 24127 Bergamo, Italy.
Carolina TerragnaIRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, 40138 Bologna, Italy.
Silvia ArmuzziIRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, 40138 Bologna, Italy.ORCID 0000-0001-6690-2590
Valentina RobustelliIRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, 40138 Bologna, Italy.
Barbara TaurisanoIRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, 40138 Bologna, Italy.
Alessandra SantoroDivision of Hematology and Bone Marrow Transplantation, Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy.
Domenico SalemiDivision of Hematology and Bone Marrow Transplantation, Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy.
Barbara IzzoDepartment of Molecular Medicine and Medical Biotechnologies & CEINGE Advanced Biotechnologies, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-7021-0367
Santa ErrichielloCEINGE Advanced Biotechnologies, University of Naples Federico II, 80145 Naples, Italy.
Alessandra GaldieroCEINGE Advanced Biotechnologies, University of Naples Federico II, 80145 Naples, Italy.
Roberta ViscontiCEINGE Advanced Biotechnologies, University of Naples Federico II, 80145 Naples, Italy.
Fabrizio QuarantelliCEINGE Advanced Biotechnologies, University of Naples Federico II, 80145 Naples, Italy.ORCID 0000-0003-0744-5734
Alessandra PotenzaCEINGE Advanced Biotechnologies, University of Naples Federico II, 80145 Naples, Italy.ORCID 0009-0001-9233-2998
Matilde Francesca CaradonnaTettamanti Center, Fondazione IRCCS San Gerardo Dei Tintori, 20900 Monza, Italy.
Matilde MarzoratiTettamanti Center, Fondazione IRCCS San Gerardo Dei Tintori, 20900 Monza, Italy.
Grazia FazioTettamanti Center, Fondazione IRCCS San Gerardo Dei Tintori, 20900 Monza, Italy.ORCID 0000-0001-7077-8422
Giovanni CazzanigaTettamanti Center, Fondazione IRCCS San Gerardo Dei Tintori, 20900 Monza, Italy.
Deborah CardinaliHematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy.
Francesca KaiserHematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy.
Ilaria D'AntuonoHematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy.ORCID 0009-0003-0147-3440
Sabina ChiarettiHematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy.
Anna GuariniHematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy.
Robin FoàHematology, Department of Translational and Precision Medicine, Sapienza University, 00161 Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Next-generation sequencing (NGS) clonality assessment has the potential to overcome the conventional limitations of PCR-based methods. This study aimed at comparing the performance and concordance of the EuroClonality-NGS approach and the LymphoTrack

Indexed as

Biomarkers, TumorHigh-Throughput Nucleotide SequencingImmunoglobulinsLeukemia, Lymphocytic, Chronic, B-CellPrecursor Cell Lymphoblastic Leukemia-LymphomaReceptors, Antigen, T-CellAdultFemaleGene RearrangementHumansMaleMiddle AgedBiomarkers, TumorImmunoglobulinsReceptors, Antigen, T-Cellacute lymphoblastic leukemia (ALL)immunoglobulin (IG) and T-cell receptor (TR)gene rearrangementsNext-generation sequencing (NGS) technology

Identifiers

PMID42278640
PMCPMC13256919

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.